JCAR017-EAP-001: Expanded Access Protocol (EAP) for Subjects Receiving Lisocabtagene Maraleucel that is Nonconforming for Commercial Release

Objective

Clinical Trial Details »

Principal Investigator(s)
Waqas Jehangir, MD

Clinical Trial Categories

  • Lymphoma
Contact
Hematology Research Coordinators at 605-322-3090
or hematologyresearch@avera.org

Location

  • Avera Cancer Institute — Sioux Falls
    1000 E 23rd St
    Suite 340
    Sioux Falls, SD 57105
    Main: 605-322-3000